Neulasta and Haloperidol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Neulasta (pegfilgrastim) and Haloperidol (haloperidol). Common drug interactions include disease recurrence among females and atrial fibrillation among males.

The phase IV clinical study analyzes what interactions people have when they take Neulasta and Haloperidol. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Neulasta?

Neulasta has active ingredients of pegfilgrastim. It is often used in agranulocytosis. eHealthMe is studying from 92,286 Neulasta users. Check the latest studies of Neulasta.

What is Haloperidol?

Haloperidol has active ingredients of haloperidol. It is often used in schizophrenia. eHealthMe is studying from 16,637 Haloperidol users. Check the latest studies of Haloperidol.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

17 people who take Neulasta and Haloperidol together, and have interactions are studied.

Neulasta and Haloperidol drug interactions.

What are the common drug interactions of Neulasta and Haloperidol, by gender? *:

female:

Disease recurrence
Dizziness
Dizziness postural
Drug ineffective
Dry mouth
Dyslipidaemia (abnormal amount of lipids)
Dyspnoea (difficult or laboured respiration)
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
Emotional distress
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)

male:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Dementia (madness)
Pulmonary cavitation (cavity in the lung)
Tachypnoea (a condition of rapid breathing over 20 per minute)
Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot)
Abdominal distension
Abdominal pain
Abnormal behaviour
Aggression
Alanine aminotransferase increased

What are the common drug interactions of Neulasta and Haloperidol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Tachypnoea (a condition of rapid breathing over 20 per minute)
Abdominal distension
Abdominal pain
Abnormal behaviour
Aggression
Alanine aminotransferase increased
Apathy
Aspartate aminotransferase increased
Blood creatine phosphokinase increased
Blood lactic acid increased

40-49:

n/a

50-59:

Device related infection
Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
Pulmonary cavitation (cavity in the lung)
Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot)

60+:

Malaise (a feeling of general discomfort or uneasiness)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Asthenia (weakness)
C-reactive protein increased
Death
Gingival bleeding (bleeding gums)
Glossitis (infection of tongue with soreness)
Salivary hypersecretion (excess saliva secretion)
Dementia (madness)
Dysphagia (a condition in which swallowing is difficult or painful)

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 8 people, 47.06%
Pain: 3 people, 17.65%
Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 3 people, 17.65%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 2 people, 11.76%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 11.76%
Fever: 1 person, 5.88%
Arrhythmias (irregular heartbeat): 1 person, 5.88%
Bleeding Disorders: 1 person, 5.88%
Breakthrough Pain: 1 person, 5.88%
Breast Cancer: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Neulasta and Haloperidol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously